Last updated: May 27, 2026
Sponsor: MGH Institute of Health Professions
Overall Status: Active - Recruiting
Phase
N/A
Condition
Speech Disorders
Communication Disorders
Treatment
Declarative learning with delayed feedback
Word learning task with passive feedback
Probabilistic learning with delayed feedback
Clinical Study ID
NCT05678634
2022P003376
Ages 8-12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- English as the primary language Nonverbal intelligence quotient (IQ) score on theWechsler Intelligence Scale for Children-5th Edition (WISC-V) Standard Score >70Identification Core score on the Test of Integrated Language & Literacy Skills (TILLS) equal to or less than 34
Exclusion
Exclusion Criteria:
Hearing loss or other known neurological deficits, or diagnoses (e.g., Autism,Traumatic Brain Injury)
Evidence of color blindness as measured by the EnChroma computer base colorblindness screening test for children
Study Design
Total Participants: 100
Treatment Group(s): 6
Primary Treatment: Declarative learning with delayed feedback
Phase:
Study Start date:
July 20, 2023
Estimated Completion Date:
October 01, 2027
Connect with a study center
MGH Institute of Health Professions
Boston, Massachusetts 02129
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.